首页> 美国卫生研究院文献>other >Integration of Global Analyses of Host Molecular Responses with Clinical Data To Evaluate Pathogenesis and Advance Therapies for Emerging and Re-emerging Viral Infections
【2h】

Integration of Global Analyses of Host Molecular Responses with Clinical Data To Evaluate Pathogenesis and Advance Therapies for Emerging and Re-emerging Viral Infections

机译:整合宿主分子反应的全球分析与临床数据以评估发病机理和针对新兴和重新出现病毒感染的先进疗法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Outbreaks associated with emerging and re-emerging viral pathogens continue to increase in frequency and are associated with an increasing burden to global health. In light of this, there is a need to integrate basic and clinical research for investigating the connections between molecular and clinical pathogenesis and for therapeutic development strategies. Here, we will discuss this approach with a focus on the emerging viral pathogens Middle East respiratory syndrome coronavirus (MERS-CoV), Ebola virus (EBOV), and monkeypox virus (MPXV) from the context of clinical presentation, immunological and molecular features of the diseases, and OMICS-based analyses of pathogenesis. Furthermore, we will highlight the role of global investigations of host kinases, the kinome, for investigating emerging and re-emerging viral pathogens from the context of characterizing cellular responses and identifying novel therapeutic targets. Lastly, we will address how increased integration of clinical and basic research will assist treatment and prevention efforts for emerging pathogens.
机译:与新出现和重新出现的病毒病原体相关的暴发继续增加频率,并与全球健康负担增加有关。有鉴于此,需要整合基础研究和临床研究,以研究分子与临床发病机制之间的联系以及治疗发展策略。在这里,我们将从临床表现,免疫学和分子特征的角度,重点讨论新兴的病毒病原体中东呼吸综合征冠状病毒(MERS-CoV),埃博拉病毒(EBOV)和猴痘病毒(MPXV)的方法。疾病以及基于OMICS的发病机理分析。此外,我们将重点介绍宿主激酶(激酶组)的全球研究在表征细胞反应和确定新的治疗靶点方面,对调查正在出现和重新出现的病毒病原体的作用。最后,我们将探讨如何加强临床和基础研究的整合,以协助对新兴病原体的治疗和预防工作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号